IE820741L - Oligosaccharide compositions - Google Patents

Oligosaccharide compositions

Info

Publication number
IE820741L
IE820741L IE820741A IE74182A IE820741L IE 820741 L IE820741 L IE 820741L IE 820741 A IE820741 A IE 820741A IE 74182 A IE74182 A IE 74182A IE 820741 L IE820741 L IE 820741L
Authority
IE
Ireland
Prior art keywords
octasaccharides
abreviation
see diagramm
denoted below
sequence
Prior art date
Application number
IE820741A
Other versions
IE52906B1 (en
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay Sa filed Critical Choay Sa
Publication of IE820741L publication Critical patent/IE820741L/en
Publication of IE52906B1 publication Critical patent/IE52906B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/02—Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2)
    • C12Y402/02007—Heparin lyase (4.2.2.7), i.e. heparinase I

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

1. Claims for the Contracting States : BE, CH, DE, GB, IT, LI, LU, NL, SE Short chained oligosaccharide compositions, characterized in that they are formed essentially of hexasaccharides having the sequence denoted below by the abreviation C'-H : see diagramm : EP0064452,P18,F1 in which R represents a hydrogen atom or the -SO3 - group and their physiologically acceptable salts. 1. Claims for the Contracting State : AT A process for the preparation of short chained oligosaccharide compositions, having the sequence denoted below by the abreviation C'-H : see diagramm : EP0064452,P19,F1 in which R represents a hydrogen atom or the -SO3 - group and their physiologically acceptable salts, characterized in that octasaccharides corresponding to the sequence ABCDEFGH (denoted below by the abreviation A-H), of the formula see diagramm : EP0064452,P20,F1 or octasaccharide compositions formed to a large extent of these octasaccharides, having a high ratio of their Yin-Wessler titer to their APTT or USP titer, are contacted, in a calcium containing buffer medium, with an enzymatic agent, said enzymatic agent having an enzymatic activity of at least 90 000 units and being applied at 0,25 to 1 mg per mg of octasaccharides treated, preferably of the order of 0.5 mg of enzymes per mg of octasaccharides, which enables to specifically fragment these octasaccharides in order to eliminate A-B units, and the major part of the active hexasaccharides C'-H are separated from the degradation mixture.
IE741/82A 1981-04-29 1982-03-29 Short chain oligosaccharides having biological properties, a process for making the same and the use thereof as drugs IE52906B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8108604A FR2504928A1 (en) 1981-04-29 1981-04-29 SHORT CHAIN OLIGOSACCHARIDES HAVING BIOLOGICAL PROPERTIES, PREPARATION THEREOF AND APPLICATIONS THEREOF AS MEDICAMENTS

Publications (2)

Publication Number Publication Date
IE820741L true IE820741L (en) 1982-10-29
IE52906B1 IE52906B1 (en) 1988-04-13

Family

ID=9257922

Family Applications (1)

Application Number Title Priority Date Filing Date
IE741/82A IE52906B1 (en) 1981-04-29 1982-03-29 Short chain oligosaccharides having biological properties, a process for making the same and the use thereof as drugs

Country Status (9)

Country Link
EP (1) EP0064452B1 (en)
JP (1) JPS57190001A (en)
AT (1) ATE12791T1 (en)
CA (1) CA1180292A (en)
DE (1) DE3263083D1 (en)
DK (1) DK189982A (en)
ES (1) ES511470A0 (en)
FR (1) FR2504928A1 (en)
IE (1) IE52906B1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2584728B1 (en) * 1985-07-12 1987-11-20 Choay Sa PROCESS FOR THE SULFATION OF GLYCOSAMINOGLYCANS AND THEIR FRAGMENTS
EP0209924A1 (en) * 1985-07-12 1987-01-28 Akzo N.V. New anti-trombosis agent based on glycosaminoglycan, process for its preparation, and pharmaceutical compositions
US5106734A (en) * 1986-04-30 1992-04-21 Novo Nordisk A/S Process of using light absorption to control enzymatic depolymerization of heparin to produce low molecular weight heparin
US5707973A (en) * 1991-04-23 1998-01-13 Rhone-Poulenc Rorer S.A. Sulfated polysaccharids for treatment or prevention of thromboses
EP0861903A1 (en) * 1997-02-22 1998-09-02 Lansing, Manfred Method for reversible immobilizing oligo and/or polysaccharides
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
FR2845686B1 (en) * 2002-10-10 2013-08-30 Aventis Pharma Sa MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2857971B1 (en) * 2003-07-24 2005-08-26 Aventis Pharma Sa MIXTURES OF HEPARIN DERIVED OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
ATE552004T1 (en) 2005-11-30 2012-04-15 Istituto G Ronzoni ORAL HEPARINE DERIVATIVES
WO2009155108A1 (en) 2008-05-30 2009-12-23 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
EP3398971A4 (en) * 2015-12-30 2019-09-25 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Sulfated heparin oligosaccharide and preparation method and application thereof
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
WO2021007429A1 (en) 2019-07-09 2021-01-14 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides
JP2021063670A (en) * 2019-10-10 2021-04-22 至 松下 Fraction collector using eluant property

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766167A (en) * 1971-03-26 1973-10-16 Research Corp Orally active anticoagulant
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
JPH0231721A (en) * 1988-07-20 1990-02-01 Matsushita Electric Ind Co Ltd Charging type cleaner

Also Published As

Publication number Publication date
FR2504928A1 (en) 1982-11-05
FR2504928B1 (en) 1984-02-24
DE3263083D1 (en) 1985-05-23
JPS57190001A (en) 1982-11-22
ES8302094A1 (en) 1983-02-01
EP0064452B1 (en) 1985-04-17
IE52906B1 (en) 1988-04-13
DK189982A (en) 1982-10-30
EP0064452A1 (en) 1982-11-10
ES511470A0 (en) 1983-02-01
ATE12791T1 (en) 1985-05-15
CA1180292A (en) 1985-01-02

Similar Documents

Publication Publication Date Title
FR2504928B1 (en)
US5578590A (en) Pharmaceutical composition preparation for use in inhibiting protein kinase C
ES312813A1 (en) Certain 6-substituted-imidazo[2, 1-b] thiazole compounds
CA2283280A1 (en) Reovirus for the treatment of neoplasia
TR200000671T2 (en) Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists.
TR200000670T2 (en) Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists.
DE3267039D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
PT85591A (en) Process for the preparation of multiple unit dosage pharmaceutical compositions comprising as a pharmaceutilly active compound l-dopa
ATE82681T1 (en) 2',3'-DIDEOXY-3'-FLUOROTHYMIDINE AND RELATED COMPOUNDS FOR THE TREATMENT OF ADENOVIRUS INFECTIONS.
EP0293751A3 (en) Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia
DE3166084D1 (en) Tricyclic cytosine derivatives for use in pharmaceutical preparations and process for their preparation
TNSN90021A1 (en) PROCESS FOR THE PREPARATION OF TETRAHYDROIMIDAZO (1,4) BENZODIAZEPIN -2- ANTIVIRAL THIONES
BR0008778A (en) Prostaglandin analogs selective for unsaturated fpc16
ES8700054A1 (en) Improved germicide composition.
BR0109617A (en) Pharmaceutical composition, oligosaccharide, process for preparing oligosaccharides, and use of oligosaccharides
GR74443B (en)
Heitlinger et al. Transport of glucose polymer-derived glucose by rabbit jejunum
ES8200363A1 (en) Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters, their preparation and pharmaceutical compositions containing them.
ES8506338A1 (en) Composition and process for the intensification of plant cultivation.
Norris Expansion of radish cotyledons: an interaction between NaCl and cytokinins
US4205081A (en) Composition and method for preventing or treating swine dysentery
JPS5513228A (en) Sterilization composition
CA2508238A1 (en) Reovirus for the treatment of neoplasia
ES2044534T3 (en) A METHOD FOR THE PREPARATION OF A THROMBOLITICALLY ACTIVE COMPOSITION.
Hjort Natural inhibitor of tissue thromboplastin.

Legal Events

Date Code Title Description
MM4A Patent lapsed